Last $3.21 USD
Change Today -0.06 / -1.83%
Volume 41.7K
OGXI On Other Exchanges
Symbol
Exchange
Munich
NASDAQ CM
As of 8:10 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

Insiders at oncogenex pharmaceutical inc (OGXI)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
Scott Cormack 13 RelationshipsFounder, Chief Executive Officer, President, Treasurer, Secretary and DirectorChief Executive Officer49

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
Jack Goldstein Ph.D. 12 RelationshipsChairman of the BoardOncoGenex Pharmaceuticals, Inc.66
Neil Clendeninn M.D., Ph.D. 5 RelationshipsMember of the Board of DirectorsCato BioVentures64
H. Parker 148 RelationshipsMember of the Board of DirectorsInfectious Disease Research Institute58
David Smith 5 RelationshipsMember of the Board of DirectorsIntegenX Inc.54
Martin Mattingly Pharm.D. 5 RelationshipsMember of the Board of DirectorsOncoGenex Pharmaceuticals, Inc.57
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OGXI:US $3.21 USD -0.06

OGXI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OGXI.
View Industry Companies
 

Industry Analysis

OGXI

Industry Average

Valuation OGXI Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOGENEX PHARMACEUTICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.